BP
Insider
Broadwood Partners, L.P.
DirectorBroadwood Partners, L.P. (Director) filed 7 Form 4 reports as a reporting entity in the trailing twelve months (7 purchases, 0 sales), most often in STAA. Across 7 priced purchase filings, the average 21-session return was +18.0% from execution and +16.5% from disclosure (delay-adjusted; derived). The largest single filing was $41.1M of STAA (1,500,000 sh across 3 lots, as filed), executed Nov 19 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+18.0%
avg across 7 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+16.5%
same 7 filings, from disclosure
Filings, ttm
7
7 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$68.4M
shares × price, as filed
Last traded
Apr 27
Filed Apr 27
Impact on $10,000 · 12M
$14,762 (+47.6%)
S&P 500 $11,725 (+17.2%) · 30.4 pts ahead
Broadwood Partners, L.P.
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $93.4M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
7 filings
Sector per market data · by filing · past 12 months
Most traded names
STAA
STAA
STAA · 6 buys · 0 sells
6 filings
IMDX
IMDX
IMDX · 3 buys · 0 sells
3 filings
OCX
OCX
OCX · 1 buy · 0 sells
1 filing
Recent filings
STAAPURCHASE
STAAR SURGICAL CO
View filing →
$941K53,969 sh across 2 lots
Exec Mar 31 2025
Filed Apr 2 2025 · 5:30 PM ET OCXPURCHASE Oncocyte Corp View filing → $10.6M
5,165,695 sh across 2 lots
Exec Feb 6 2025
Filed Feb 10 2025 · 5:30 PM ET